Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vilma Alanko"'
Autor:
Sára Mravinacová, Vilma Alanko, Sofia Bergström, Claire Bridel, Yolande Pijnenburg, Göran Hagman, Miia Kivipelto, Charlotte Teunissen, Peter Nilsson, Anna Matton, Anna Månberg
Publikováno v:
Molecular Neurodegeneration, Vol 19, Iss 1, Pp 1-15 (2024)
Abstract Background Amyloid and tau aggregates are considered to cause neurodegeneration and consequently cognitive decline in individuals with Alzheimer’s disease (AD). Here, we explore the potential of cerebrospinal fluid (CSF) proteins to reflec
Externí odkaz:
https://doaj.org/article/510df6556edb428db18f5039ba357301
Autor:
Vilma Alanko, Adhara Gaminde‐Blasco, Tania Quintela‐López, Raúl Loera‐Valencia, Alina Solomon, Ingemar Björkhem, Angel Cedazo‐Minguez, Silvia Maioli, Graziella Tabacaru, María Latorre‐Leal, Carlos Matute, Miia Kivipelto, Elena Alberdi, Anna Sandebring‐Matton
Publikováno v:
Glia. 71:1414-1428
Autor:
Makrina Daniilidou, Francesca Eroli, Vilma Alanko, Julen Goikolea, Maria Latorre-Leal, Patricia Rodriguez-Rodriguez, William J Griffiths, Yuqin Wang, Manuela Pacciarini, Ann Brinkmalm, Henrik Zetterberg, Kaj Blennow, Anna Rosenberg, Nenad Bogdanovic, Bengt Winblad, Miia Kivipelto, Delphine Ibghi, Angel Cedazo-Minguez, Silvia Maioli, Anna Sandebring-Matton
Alzheimer’s disease is a multifactorial disorder with a heterogeneous patient population. Comorbidities such as hypertension, hypercholesterolemia and diabetes are known contributors to the disease progression. Indeed, therapies targeting these dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b537755f045232c5cf0feafb7cc47dba
https://doi.org/10.1101/2022.06.09.495140
https://doi.org/10.1101/2022.06.09.495140
Autor:
Vilma Alanko, Raúl Loera‐Valencia, Alina Solomon, Ingemar Björkhem, Angel Cedazo Minguez, Silvia Maioli, Graziella Tabacaru, Maria Latorre Leal, Fokion Spanos, Tania Quintela‐López, Adhara Gaminde‐Blasco, Carlos Matute, Miia Kivipelto, Elena Alberdi, Anna Sandebring‐Matton
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Adhara Gaminde-Blasco, Graziella Tabacaru, Elena Alberdi, Ingemar Björkhem, Tania Quintela-López, Miia Kivipelto, María Latorre-Leal, Raúl Loera-Valencia, Angel Cedazo-Minguez, Vilma Alanko, Alina Solomon, Anna Matton, Carlos Matute, Silvia Maioli
Background: Midlife hypercholesterolemia is a risk factor for dementia, possibly via vascular-related pathways. Another proposed factor linking elevated systemic cholesterol levels and neurodegenerative diseases is the oxidized cholesterol metabolite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f67ef2754428ec472a51725e82c4e74
https://doi.org/10.21203/rs.3.rs-459275/v1
https://doi.org/10.21203/rs.3.rs-459275/v1